Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (61-70 of 381) with videos related to

Pageof 39
Sort By:
The New England Journal of Medicine|December 16, 2020
Avelumab Maintenance for Urothelial CarcinomaVeronica Mollica, Alessandro Rizzo, Francesco Massari
Future Oncology (London, England)|July 14, 2020
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancerVeronica Mollica, Alessandro Rizzo, Francesco Massari
Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 18, 2020
Combination therapy of dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutated biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Chaos (Woodbury, N.Y.)|July 12, 2021
How adherence to public health measures shapes epidemic spreading: A temporal network modelBrandon M Behring, Alessandro Rizzo, Maurizio Porfiri
The Lancet. Oncology|January 1, 2022
Second-line liposomal irinotecan plus fluorouracil and leucovorin in metastatic biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Immunotherapy|April 6, 2021
Atezolizumab in advanced hepatocellular carcinoma: good things come to those who waitAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Treatment and Research Communications|April 2, 2021
IDH inhibitors in advanced cholangiocarcinoma: Another arrow in the quiver?Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Control : Journal of the Moffitt Cancer Center|August 19, 2020
Immunotherapy in Biliary Tract Cancer: Worthy of a Second LookAngela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology|November 20, 2020
Recent advances of immunotherapy for biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancers|February 4, 2021
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract CancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Pageof 39

Showing results (61-70 of 381) with videos related to

Sort By:
Pageof 39
The New England Journal of Medicine|December 16, 2020
Avelumab Maintenance for Urothelial CarcinomaVeronica Mollica, Alessandro Rizzo, Francesco Massari
Future Oncology (London, England)|July 14, 2020
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancerVeronica Mollica, Alessandro Rizzo, Francesco Massari
Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 18, 2020
Combination therapy of dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutated biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Chaos (Woodbury, N.Y.)|July 12, 2021
How adherence to public health measures shapes epidemic spreading: A temporal network modelBrandon M Behring, Alessandro Rizzo, Maurizio Porfiri
The Lancet. Oncology|January 1, 2022
Second-line liposomal irinotecan plus fluorouracil and leucovorin in metastatic biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Immunotherapy|April 6, 2021
Atezolizumab in advanced hepatocellular carcinoma: good things come to those who waitAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Treatment and Research Communications|April 2, 2021
IDH inhibitors in advanced cholangiocarcinoma: Another arrow in the quiver?Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Control : Journal of the Moffitt Cancer Center|August 19, 2020
Immunotherapy in Biliary Tract Cancer: Worthy of a Second LookAngela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology|November 20, 2020
Recent advances of immunotherapy for biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancers|February 4, 2021
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract CancerAlessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Pageof 39